A modified and improved spin membrane immunoassay has been developed for detecting complement-activating antibodies to Neisseria meningitidis capsular polysaccharide antigens. The polysaccharides were incorporated in the membranes of large unilamellar vesicles prepared by the reverse-phase evaporation method and filled with the water-soluble spin label tempocholine chloride. Upon addition of group-specific antisera and complement, the lipid membrane was damaged and the spin label leaked out. This process was monitored by electron spin resonance spectroscopy. A satisfactory assay was developed for polysaccharides of group A and C, whereas in the case of the B system the assay was more labile. The method is rapid and has a sensitivity comparable to that of radioimmunoassay. When studying paired sera from five recruits vaccinated with an A+C polysaccharide vaccine, significant rises in titers to both A and C polysaccharides were observed in all the postvaccination sera.
During the last decade there has been rapid progress in the development of appropriate vaccines for bacterial meningitis. Based on the initial efforts of Goldschneider et al. (8, 9) and Gotschlich et al. (11, 12) , highly purified highmolecular-weight capsular polysaccharide vaccines have been developed and successfully used for the prevention of disease due to infections of Neisseria meningitidis of the serogroups A and C. In contrast, B polysaccharide has been found to be nonimmunogenic in humans (29) . Recently, vaccines composed of noncovalent complexes of B polysaccharides and lipopolysaccharide-depleted outer membrane material from group B meningococci have been shown to give immune responses in vaccinees (33) .
The effect of a vaccine has to be evaluated by some serological assay before it may be tested for protection. For meningococcal antibodies, the most important methods are the bactericidal activity test (BCA) (7, 8) , the passive hemagglutination test (2), the radioimmunoassay (RIA) (17) or solid phase RIA (30) , and the enzymelinked immunosorbent assay (7) .
A problem when comparing the results of the different tests is that they do not measure the same parameters. Some measure antibodies against the polysaccharides only, others against outer membrane proteins as well. In some tests, immunoglobulin G (IgG) dominates the response, in others, IgM dominates. Hence, the different methods often given complementary information. Furthermore, the sensitivity, the convenience in use, and the time needed for the analysis vary from test to test. Although the RIA and solid phase RIA tests are rapid and sensitive methods for quantitating A and C polysaccharide-binding antibodies, no good test has been developed for anti-B antibodies or exclusively for complement-activating antipolysaccharide antibodies when the antigen is located in a membraneous environment. Attempts to develop a complement-fixation test with purified polysaccharide antigens have met with failure (2). The BCA assay is assumed to be the best measure of the immune status of an individual. The test is, however, both time and reagent consuming, and it is difficult to standardize the assay. The results will not tell us about specificity of the antibodies nor exactly against what antigens they are directed. A sensitive and rapid assay for detecting complement-activating antibodies against the group-specific polysaccharides would therefore be of great clinical and theoretical value.
The work of Gotschlich et al. (10) made it clear that the capsular polysaccharides from the meningococci have a hydrophobic 1,2-diacylglycerol end. This should, in principle, enable these substances to be incorporated into or attached to the membranes of artificial vesicles or liposomes produced from phospholipids. By adding specific antibodies and complement to polysaccharide-sensitized liposomes filled with a marker substance, immune lysis can be utilized in an assay for complement-activating antibodies 906 VISTNES, ROSENQVIST, AND FR0HOLM analogous to the BCA test.
Kinsky and co-workers (18) developed the first immunoassay based on immune lysis of liposomes filled with glucose. Later, Humphries and McConnell (15) used a spin label as marker to obtain a more sensitive system. The basic idea in the spin membrane immunoassay (SMIA) is to load vesicles with spin label in high concentration. The exchange interaction broadens and decreases the amplitude of the electron spin resonance (ESR) absorption lines. When the spin label is released from the vesicles, the local concentration, and thus the exchange interaction, is markedly reduced. The absorption lines then become narrow and the amplitude greatly enhanced. Unlike the RIA method, SMIA does not require separation procedures and involves no radiation hazard. It has the advantage of speed, the possibility offull automation, simplicity, and a small sample volume (30 ,ul In this work, we present a modified and improved SMIA technique developed for detecting antibodies to meningococcal capsular polysaccharide antigens.
MATERIALS AND METHODS Lipids. Egg yolk phosphatidylcholine was purchased from Avanti Biochemicals Inc., Birmingham, Ala., and cholesterol and L-a-dipalmitoyl phosphatidic acid were from Sigma Chemical Co., St. Louis, Mo.
Complement. Serum from 4-week-old rabbits which were shown to be nonbactericidal in BCA tests, were used as a source of complement. It was stored in small samples at -25°C for a maximum of 3 months and thawed just before use.
Antisera. Meningococcal agglutinating sera, containing rabbit antibodies against N. meningitidis group A, B, or C, which had been adsorbed as necessary to render them group specific in agglutination tests, were purchased from Wellcome Reagents Ltd., Beckenham, England. Also, a human serum, taken 3 weeks after immunization with a Men A+C capsular polysaccharide vaccine, was used as a reference serum. This serum (the HK serum) was kindly given to us by Helena Kayhty, Central Public Health Laboratory, Helsinki, Finland. It contained 2 ,ug of anti-A antibodies per ml and 21 ,ug of anti-C antibodies per ml as determined by Kayhty by radioimmunoassay (17) .
As a reference in the group B system, we also used a mouse ascites fluid (2-1-B) containing monoclonal antibodies of the IgM class directed against the B capsular polysaccharide from meningococci (30 Preparation of vesicles. Large unilamellar vesicles were made by the reverse-phase evaporation technique (24) with small modifications. The lipid composition was phosphatidylcholine-cholesterol-L-a-dipalmitoylphosphatidic acid (60:35:5) (mole fractions), and typically, 10 ,umol of lipid and 1 ml of aqueous phase were used. The aqueous phase was a mixture of 400 ,ul of 150 mM spin label tempocholine chloride, prepared as described in reference 19, 400 pl of iso-osmolar veronal buffer, and 200 F±l of water. The polysaccharides were added to the aqueous phase from which it becomes incorporated in the membrane. The isoosmolar veronal buffer was made of 145 mM NaCl, 3.1 mM diemal, 0.97 mM sodium diemal, 0.83 mM MgCl2 and 0.19 mM CaC12, and the pH was 7.2. A hyperosmolar buffer was made in the same way, but with 1.5 times the concentration used in the iso-osmolar buffer.
The vesicles were washed for untrapped spin label either by dialysis or by passing the preparation through a Sepharose CL-2B column equilibrated with the iso-osmolar veronal buffer. The reproducibility of the unilamellar vesicle preparations, as judged from the trapping efficiency (volume per mole of lipid) was relatively high (standard deviation of 20 to 30%). The vesicles were stored at room temperature and diluted extensively before use in the assay. Typically, in the final test, the lipid concentration was 20 nmol of lipid per ml.
SMIA. A 30-pl amount of antiserum diluted in veronal buffer was mixed with 10 ptl of the hyperosmolar veronal buffer. To this solution, 10 pul of vesicles, diluted in isotonic veronal buffer, were added followed by 10 pul of complement solution. The sample was incubated under shaking at 37°C for 10 min, taken up in 50-pA capillary tubes, sealed with Sigillum wax on June 27, 2017 by guest http://jcm.asm.org/ Downloaded from (Modulohm, Denmark), and incubated for 10 min more at room temperature before ESR recording. Alternatively, the incubation was for 20 min at 37°C, directly followed by ESR recording at room temperature. The two different incubation schemes gave identical results.
ESR measurements. The ESR signal intensity was recorded on a Bruker ER-200-D ESR spectrometer equipped with a rectangular cavity. The modulation amplitude and frequency were 1.25 G and 100 kHz, respectively, and a microwave power of 20 mW was used. The capillary with the sample was placed in a 3-mm outer diameter quarts tube, and the solution completely filled the part of the capillary tube inside the cavity. The amplitude of the midfield line was determined by using the g-value controlled device as previously described (26, 28) . The amplitude could also be determined in the conventional way (23) , but with reduced efficiency and accuracy.
RESULTS
Background release. The absolute amount of spin label released from the vesicles was determined basically as described before (23) . Thus, a sample in which buffer was exchanged for antiserum and complement gave, by definition, 0% release. The value obtained by adding Triton X-100 (final concentration 2%) was defined as 100% release. A linear dose-response curve between these two limits was assumed. The background release of spin label due to serum or complement-induced nonimmune-specific lysis was minor. During the incubation it typically was only a few percent.
It was found that the phospholipid composition of the vesicles influenced markedly the background release. Vesicles in which phosphatidylserine or dicetyl-phosphate was the negatively charged lipid instead of phosphatidic acid often possessed an enhanced nonspecific lysis. As also observed by Allen and Cleland (1), the nonspecific lysis of vesicles induced by serum or complement was higher if the hyperosmotic buffer was not included in the reaction mixture.
In spite of efforts in choosing the optimal phospholipid composition and osmotic conditions, the nonspecific lysis and the "natural leakage" from vesicles with polysaccharides in the membrane was higher than for our previously tested systems (22, 23) . Thus, vesicles typically had to be used within 8 h after they were removed from the dialysis bag and were generally unsuitable after 3 days from the first washing procedure. Because of leakage and nonspecific lysis, the amplification factor in ESR amplitudes for a positive serum response relative to a negative serum response was only a factor of 2 to 10 but was sufficient to detect a positive response.
Immune lysis. When capsular polysaccharides were incorporated in the vesicles, the addition of group-specific antipolysaccharide antibodies and rabbit complement induced lysis of the vesicles, as monitored by a rapid increase in the ESR amplitude. The lytic reaction followed the same kinetics as observed in our previous systems (23) . The reaction was complete after 30 min at room temperature or 10 min at 370C. No significant lysis beyond the nonspecific one discussed above was observed unless all of the following three components were present: antiserum (antibodies), active complement, and polysaccharides incorporated in the membrane (Fig. 1) .
With a constant amount of complement per sample, the maximum immune lysis when titrating an antiserum was apparently independent of the actual antiserum. This maximum immune lysis was defined as 100% immune lysis and corresponded to 40 to 80% of the Triton X-100 release of spin label. The 0% immune lysis was defined as the degree of lysis after incubation with only complement and buffer. Again, a linear relationship between ESR amplitudes and the corresponding percent immune lysis was adopted between the 0 and 100% limits.
At the polysaccharide concentrations tested (6 to 25 ,ug of polysaccharide per ,umol of lipid), the degree of lysis and the sensitivity of the test were fairly independent of the antigen concentration.
Group-specific rabbit antisera (meningococcal agglutinating sera from Wellcome Laboratories Ltd.) were tested for cross-reactivity. For most combinations of antisera and vesicles, the crossreactivity between the A, B, and C systems was very low. Typically, the titer for one groupspecific antiserum dropped by a factor of 100 or more when its own group polysaccharide was replaced by that of another serogroup. The only exception from this was the anti-C antiserum that showed a titer for the B test system of about 1/10 of the titer for the C test system. On the other hand, with the monoclonal anti-B antibodies and the C test liposomes, the titer was reduced to about 1/100 of the titer with the B liposomes.
The release of spin label versus antibody concentration for the group A test system is given in Fig. 2 . The results corresponding to two different complement concentrations are shown, and the lower concentration gave a typical prozone. For the higher complement concentration, the immune lysis showed a plateau followed by a fall at a higher antibody dilution.
The shapes of the antibody dilution curves for the A, B, and C test systems appeared to be similar when antisera from the same species were compared. Strong and weak antisera differed mainly by horizontal displacements of the curves (Fig. 1) . To indicate the relative strength of the antisera, the serum dilution corresponding to 20% immune lysis is defined as the titer of that serum. The procedure is illustrated in Fig. 1 behaved very much like the pure A system, mune lysis suddenly began to decrease from the esponded now to both anti-A and anti-C maximum value to nearly zero within a few Ddies. The pure group C polysaccharide-hours. This effect was also observed to some d liposomes also responded very similarly degree for the liposomes made from group C above-mentioned systems. The B polysac-polysaccharides but not from those prepared de system, however, tended to give less from the lactose-stabilized vaccines. ducible results. The maximum lysis was Sensitivity. By using the quantitation procewhat lower (40 to 60% of Triton X-100 dure discussed above, the HK reference serum se) and varied considerably for different had a titer of about 2,000 in the group A polysacrations of liposomes and different antisera. charide system and about 7,000 in the C system. the group B polysaccharides, the test sys-With a concentration of 2 ,g/ml for anti-A ras also degraded by time. About 30 to 40 h antibodies and 21 ,ug/ml for anti-C antibodies the vesicles were made, the percent im-(determined by RIA anti-C antibodies in case no. 5. In the postvaccination sera, we found that all had responded significantly to the vaccine, both with anti-A and anti-C antibodies. After 20 weeks, there was a drop in antibody titers, most obvious for the anti-C antibodies. When the paired sera from the five vaccinees who had received the combined group B polysaccharide and type 2 outer membrane protein vaccine were analyzed with the B system, we could not find significant (more than twofold) rise in titers against B polysaccharides for any of the vaccinees. However, the instability of the B system discussed above made it difficult to be sure about such small changes in the titer. It should also be mentioned that by using the enzyme-linked immunosorbent assay technique, significant increases of antibodies against outer membrane antigen from a noncapsular variant of a type 2, group B meningococcus was found in all of the five postvaccination sera. DISCUSSION The present immunological technique is the only one developed so far which tests for complement-activating antibodies against isolated meningococcal capsular polysaccharides incorporated in a lipid membrane. The immunoglobulins detected are of both IgG and IgM class. Since we have not compared our results with the results from other methods (hemagglutination assay, RIA, enzyme-linked immunosorbent assay, BCA), we can not draw conclusions about the correlation between the various methods. However, hemagglutination assay detects mainly IgM antibodies (2), whereas the BCA test preferentially measures IgG antibodies (11) , and by enzyme-linked immunosorbent assay and RIA, we can make the test class specific. Although there is shown to be a correlation between hemagglutination assay, RIA, and BCA antibodies against group A capsular polysaccharides (16), the only test that has been successfully correlated with immunity, and therefore can be used for determination of the immune status, is the BCA test. Probably our SMIA assay is similar to the BCA test, and in addition it has the advantage of being able to study separately the different antigens. To get a full understanding of the immunological response by meningococcus vaccination, both classes and subclasses of the antibodies as well as opsonins and antibodydependent cellular cytotoxicity should be analyzed.
The assay worked very satisfactorily with group A and C polysaccharides, whereas with group B polysaccharides the system was instable. The reason for the instability of the B system may either be due to the particular sample of B polysaccharide that was available or it may be a general feature of this antigen. It is reported that the B polysaccharides are much more acid labile than the other groups of capsular polysaccharides (29) and spontaneously forms internal esters below pH 6 (20) . The instability might also be related to some degradation of the polysaccharides when lyophilized without stabilizer. The C test system, prepared from polysaccharides without lactose, also tended to be degraded over time, although not to the same degree as the B system. This observation might be of interest in connection with an attempted production of a B polysaccharide vaccine. It should be noted, however, that the sudden drop in immune lysis observed did not seem to occur to the same degree and time for all sera.
Apparently, the sensitivity, given in micrograms per milliliter, was 30 to 100 times better for the A and C systems than for the B system, but since the anti-B antibodies available were pure IgM, whereas the anti-A and anti-C antibodies presumably were mainly IgG molecules, this difference is lower on a molar basis.
It should be pointed out here that the titer is only indirectly related to the absolute amount of the particular antibody per milliliter. However, the titer might be an equally good way, if not better, for giving a physiological measure of the immune potential, since now both the number and the avidity of the antibodies influence the result (6) .
The difference in sensitivity between the A, C, and B systems probably reflects differences in avidity and binding constants between anti-C and anti-B antibodies. Mandrell and Zollinger (21) have found that at 37°C, both "natural" human anti-C and mouse monoclonal anti-C antibodies had binding constants 20 to 30 times higher than human anti-B or mouse monoclonal anti-B antibodies. In their experiments, they used the same monoclonal anti-B antibody as we did (2-1-B). In the BCA test, human anti-B antibodies require rabbit complement to be bactericidal, whereas with human complement only antibodies against noncapsular antigens were bactericidal (31) . Thus, the problems with the B system in SMIA may suggest some interaction between rabbit complement and whole bacteria in the BCA test.
In analyzing the relative strength of different antisera, we observed also that sera with similar titers following our definition, like the rabbit anti-A serum (WA) and the human anti A+C serum (HK), gave distinctly different titration curves with A polysaccharide-coated liposomes (Fig. 3) *n.
The same may be the situation with liposomes.
We find that the prozone can be overcome either by reducing the amount of antibody or by in-''--' ' 'creasing the amount of complement. by statistical methods, and it was meningitidis could probably be incorporated in at the microscopical dissociation con-the vesicle membrane in a way similar to the for the antibody-antigen reaction were polysaccharides and allow the development of for the two sera (A. I. Vistnes, submit-additional specific and sensitive serological astublication). Differences 
